Floatz logo

1,25-dihydroxyvitamin d

Vitamin D Deficiency

University Hospital RijekaPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Vitamin D Deficiency cohort.

Asset / SponsorPhaseRating
VITAMIN D
Yale University
Phase 4A
Metformin
Ain Shams University
Phase 4BBB
Letrozole
Umm Al-Qura University
Phase 4BB
ERGOCALCIFEROLUM
Chulalongkorn University
Phase 4BB
Clomifene
Ain Shams University
Phase 4B

View all 16 →

Same molecule, other indications

1,25-dihydroxyvitamin d is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →